HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth Ralfkiaer Selected Research

DNA (Deoxyribonucleic Acid)

7/2017Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.
8/2002ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth Ralfkiaer Research Topics

Disease

11Lymphoma (Lymphomas)
04/2016 - 09/2003
8Neoplasms (Cancer)
07/2017 - 08/2002
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2016 - 08/2003
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2013 - 11/2006
5Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2015 - 06/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 11/2006
3Pathologic Complete Response
05/2014 - 09/2012
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2012 - 05/2009
3Inflammation (Inflammations)
11/2011 - 08/2009
2T-Cell Lymphoma (Lymphoma, T Cell)
12/2015 - 05/2009
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2015 - 09/2012
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2015 - 07/2014
2Primary Myelofibrosis (Myelosclerosis)
03/2012 - 12/2003
1Multiple Myeloma
01/2019
1Eye Neoplasms (Eye Cancer)
12/2017
1Starvation
07/2016
1Infertility (Sterility)
11/2012
1Leukemia
11/2012
1Skin Diseases (Skin Disease)
11/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2011
1Dermatitis
11/2011
1Mycosis Fungoides
10/2010
1Infections
07/2010
1Necrosis
08/2009
1Disease Progression
07/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2008
1Melanoma (Melanoma, Malignant)
03/2004
1Leukocytosis (Pleocytosis)
12/2003
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2003
1Dizziness (Lightheadedness)
12/2003
1Subdural Hematoma (Subdural Hemorrhage)
12/2003
1Thrombocytosis (Thrombocythemia)
12/2003

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
12/2017 - 05/2014
4Proteins (Proteins, Gene)FDA Link
12/2015 - 09/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
11/2016 - 05/2014
2DNA (Deoxyribonucleic Acid)IBA
07/2017 - 08/2002
2Biomarkers (Surrogate Marker)IBA
07/2017 - 07/2009
2CytokinesIBA
07/2016 - 08/2009
2Anaplastic Lymphoma KinaseIBA
12/2015 - 09/2012
2MicroRNAs (MicroRNA)IBA
04/2014 - 11/2011
2EpitopesIBA
03/2012 - 03/2004
1Thalidomide (Thalomid)FDA Link
01/2019
1pomalidomideIBA
01/2019
1Immunomodulating AgentsIBA
01/2019
1Lenalidomide (CC 5013)FDA Link
01/2019
1Cell-Free Nucleic AcidsIBA
07/2017
1Interleukin-2 (IL2)IBA
07/2016
1Lymphotoxin-alpha (Lymphotoxin)IBA
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2014
1ibritumomab tiuxetan (Zevalin)FDA Link
05/2014
1Prednisone (Sone)FDA LinkGeneric
05/2014
1Etoposide (VP 16)FDA LinkGeneric
05/2014
1Vincristine (Oncovin)FDA LinkGeneric
05/2014
1Melphalan (Alkeran)FDA LinkGeneric
05/2014
1A-Form DNA (A-DNA)IBA
12/2013
1imidazole mustard (BIC)IBA
06/2013
1Interleukin-17 (Interleukin 17)IBA
06/2011
1VorinostatFDA Link
12/2010
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
10/2010
1IronIBA
07/2010
1FerrichromeIBA
07/2010
1SiderophoresIBA
07/2010
1Lipocalin-2IBA
07/2010
1factor AIBA
08/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2009
1Phosphotransferases (Kinase)IBA
06/2009
1NF-kappa B (NF-kB)IBA
06/2009
1Histone Deacetylase 1IBA
05/2009
1Histone Deacetylase InhibitorsIBA
05/2009
1Histones (Histone)IBA
05/2009
1Histone Deacetylases (Histone Deacetylase)IBA
05/2009
1Reduced Folate Carrier ProteinIBA
01/2008
1Messenger RNA (mRNA)IBA
11/2006
1MetallothioneinIBA
11/2006
1Neoplasm Antigens (Tumor Antigens)IBA
03/2004
1SurvivinIBA
03/2004
1HLA-A2 Antigen (HLA A2 Antigen)IBA
03/2004
1Peptides (Polypeptides)IBA
03/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2003
1Imatinib Mesylate (Gleevec)FDA Link
12/2003
1fas Receptor (CD95 Antigen)IBA
09/2003
1AntigensIBA
09/2003

Therapy/Procedure

9Drug Therapy (Chemotherapy)
12/2017 - 08/2003
7Stem Cell Transplantation
11/2016 - 08/2003
4Therapeutics
11/2016 - 05/2009
4Radiotherapy
04/2016 - 10/2011
3Transplantation
11/2012 - 12/2010
1Combination Drug Therapy (Combination Chemotherapy)
04/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2012
1Replantation
11/2012
1Aftercare (After-Treatment)
01/2008
1Induction Chemotherapy
08/2003